Brief: Ikena Oncology Reports Q4, Full Year 2021 Financial Results
17/03/2022 11:18
March 17 (Reuters) - Ikena Oncology Inc IKNA.O :
* IKENA ONCOLOGY REPORTS FOURTH QUARTER AND FULL YEAR 2021
FINANCIAL RESULTS AND CORPORATE UPDATE
* IKENA ONCOLOGY INC - CASH RUNWAY THROUGH FIRST HALF 2024
* IKENA ONCOLOGY INC QTRLY NET INCOME PER SHARE ATTRIBUTABLE
TO
COMMON STOCKHOLDERS - DILUTED$0.07
Source text for Eikon: ID:nGNX8c0nrH
Further company coverage: IKNA.O
Recent news on ImageneBio
See all newsU.S. STOCKS ON THE MOVE-Conagra, Oracle, Replimune
U.S. STOCKS ON THE MOVE-Allogene Therapeutics, Adobe, Williams-Sonoma
Brief: ImageneBio Inc - On Oct 23, Elects Not To Renew Agreement With Miragene - SEC Filing
ImageneBio Inc expected to post a loss of $1.56 a share - Earnings Preview
Brief: Ikena Oncology Announces Stockholder Approval Of Merger With Inmagene Biopharmaceuticals